Department of Child and Adolescent Psychiatry, University of Cologne, Robert-Koch-Str. 10, 50931, Cologne, Germany.
Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S289-96. doi: 10.1007/s00787-011-0206-0.
DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data from a proof-of-concept study and two observational trials (Medikinet(®) retard [methylphenidate] and the Equasym XL(®) [methylphenidate] OBSEER study) evaluated: (1) validity of weekly externalising symptom ratings using DAYAS, in place of daily ratings; (2) reliability and internal consistency of DAYAS ratings for externalising symptoms and potentially medication-related symptoms; and (3) convergent and divergent validity of the externalising symptom ratings with existing validated scales. From the proof-of-concept study, daily scores by period of day and during the whole day correlated strongly with equivalent weekly scores (r = 0.83-0.92). Internal consistency of externalising symptom rating scales calculated from pooled data were acceptable or good by period of day (Cronbach's alpha = 0.68-0.90) and very high for whole day scores (Cronbach's alpha = 0.88-0.95). Internal consistency of the rating scale for potentially medication-related symptoms was also good for both teacher and parent ratings. From OBSEER data, correlations between FBB-ADHD total symptom scores and ratings on both parent and teacher versions of DAYAS were high (r = 0.73 and r = 0.84, respectively). Correlations between DAYAS and SDQ were highest for the SDQ subscales hyperactivity and conduct problems and substantially lower for pro-social behaviour, peers and emotional problems. The DAYAS rating scale had good internal consistency, and DAYAS scores correlated well with existing validated scales and the SDQ subscales hyperactivity and conduct problems. Weekly DAYAS scores (whole day and by period of day) could be considered a suitable replacement for daily assessment scores.
DAYAS 是一个新的两部分评分量表,用于评估:(1)ADHD 和 ODD 症状(外化症状评分)和(2)在正常上学日的不同时间段的真实环境下可能与 ADHD 药物相关的症状(潜在药物相关症状)。来自概念验证研究和两项观察性试验(Medikinet(®)缓释[哌醋甲酯]和 Equasym XL(®)[哌醋甲酯]OBSEER 研究)的数据评估了:(1)使用 DAYAS 替代每日评分,每周外化症状评分的有效性;(2)外化症状和潜在药物相关症状的 DAYAS 评分的可靠性和内部一致性;(3)外化症状评分与现有验证量表的相关性和发散性。从概念验证研究中,每天按时间段和全天的分数与等效每周分数高度相关(r = 0.83-0.92)。按时间段计算的外化症状评分量表的内部一致性在 pooled 数据中是可接受或良好的(Cronbach's alpha = 0.68-0.90),全天得分非常高(Cronbach's alpha = 0.88-0.95)。潜在药物相关症状评分量表的内部一致性对于教师和家长评分也是良好的。从 OBSEER 数据中,FBB-ADHD 总分症状评分与 DAYAS 的家长和教师版本评分之间的相关性很高(r = 0.73 和 r = 0.84)。DAYAS 与 SDQ 的相关性最高的是 SDQ 分量表多动和品行问题,而亲社会行为、同伴和情绪问题的相关性则较低。DAYAS 评分量表具有良好的内部一致性,并且 DAYAS 分数与现有验证量表和 SDQ 分量表多动和品行问题相关性良好。每周 DAYAS 评分(全天和按时间段)可作为每日评估评分的合适替代。